Results 171 to 180 of about 21,414,113 (306)

Protecting women's health in sport: the role of low energy availability in the Female Athlete Triad and RED-S. [PDF]

Front Sports Act Living
Ghazzawi HA, Khataybeh B, Al Aqaili R, Alnimer L, Omoush RM, Ali HA.   +5 more
europepmc   +1 more source

Preparation and Characterization of Magnetite Talc (Fe₃O₄@Talc) Nanocomposite as an Effective Adsorbent for Cr(VI) and Alizarin Red S Dye. [PDF]

Materials (Basel), 2022
Nayl AA, Abd-Elhamid AI, Ahmed IM, Bräse S.   +3 more
europepmc   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

Molecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi, Stavros Makrodimitris, Sandra van Wilpe, Iris te Paske, Vanja de Weerd, Corine M. Beaufort, Hans M. Westgeest, Jens Voortman, Maureen J. B. Aarts, Maud Rijnders, Astrid A. M. van der Veldt, Ronald de Wit, Niven Mehra, Saskia M. Wilting, Debbie G. J. Robbrecht   +14 more
wiley   +1 more source

Annual Report - Australian Red Cross Blood Service

, 1996
This record was harvested from a previous catalogue system and will be withdrawn in 2025. Information in this record may be superseded or incomplete.
Australian Red Cross Society, National Office
core  

Synthesis and characterization of novel zinc-organic framework for the effective removal of Alizarin Red S. [PDF]

Sci Rep
Abdelwahab MA, Abdelhamid AM, Eliwa AS, Abdelhamid AM, Abdelhady S, Auf S, Awad HA, Abdelkader RM, Ghanem J, Mohamed MH, Gamaleldin M, Ali SA, Mohamed GG, Alhelf M.   +13 more
europepmc   +1 more source

Energy Availability and RED-S Risk Factors in Competitive, Non-elite Male Endurance Athletes. [PDF]

Transl Med Exerc Prescr, 2021
Lane AR, Hackney AC, Smith-Ryan AE, Kucera K, Register-Mihalik JK, Ondrak K.   +5 more
europepmc   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

Molecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir, Adrián López García de Lomana, Thejus B. Venkatesh, Kritika Kirty, Snaevar Sigurdsson, Linda Vidarsdottir, Ramile Dilshat, Erla Sveinbjornsdottir, Snaedis Ragnarsdottir, Daniel H Magnusson, Maria R. Bustos, Eirikur Steingrimsson, Thorkell Gudjonsson, Stefan Sigurdsson   +13 more
wiley   +1 more source

Implementation and Feasibility of the Re-Engineered Discharge for Surgery (RED-S) Intervention: A Pilot Study. [PDF]

J Healthc Qual, 2021
Du RY, Shelton G, Ledet CR, Mills WL, Neal-Herman L, Horstman M, Trautner B, Awad S, Berger D, Naik AD.   +9 more
europepmc   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

Cow dung waste as an eco-friendly adsorbent for Alizarin Red S dye removal. [PDF]

Sci Rep
El-Rayyes A, Babatimehin AM, Refat MS, Alsuhaibani AM, Bamigbade AA, Ilesanmi NY, Ofudje EA.   +6 more
europepmc   +1 more source